Aebischer CP, Schierle J, Schüep W (1999) Simultaneous determination of retinol, tocopherols, carotene, lycopene, and xanthophylls in plasma by means of reversed-phase high-performance liquid chromatography. Methods Enzymol 299, 348–362.
Bartlett H, Eperjesi F (2003) Age-related macular degeneration and nutritional supplementation: a review of randomized controlled trials. Ophthal Physiol Opt 23, 383–399.
Beatty S, Boulton M, Henson D, Koh HH, Murray IJ (1999) Macular pigment and age related macular degeneration. Br J Ophthalmol 83, 867–877.
Beatty S, Koh H, Henson D, Boulton M (2000) The role of oxidative stress in the pathogenesis of age-related macular. Surv Ophthalmol 45, 115–134.
Benzie IFF (2003) Evolution of dietary antioxidants. J Comp Biochem Physiol 136, 113–126.
Bone RA, Landrum JT, Dixon Z, Chen Y, Llerena CM (2000) Lutein and zeaxanthin in the eyes, serum and diet of human subjects. Exp Eye Res 71, 239–245.
Bone RA, Landrum JT, Guerra LH, Ruiz CA (2003) Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr 133, 992–998.
Breithaupt DE, Weller P, Wolters M, Hahn A (2004) Comparison of plasma responses in human subjects after the ingestion of 3R,3R'-zeaxanthin dipalmitate from wolfberry ( Lycium barbarum ) and non-esterified 3R,3R'-zeaxanthin using chiral high-performance liquid chromatography. Br J Nutr 91, 707–713.
Castenmiller JJM, West CE (1998) Bioavailability and bioconversion of carotenoids. Ann Rev Nutr 18, 19–39.
Edge R, McGarvey DJ, Truscott TG (1997) The carotenoids as anti-oxidants – a review. J Photochem Photobiol B 41, 189–200.
Hammond BR Jr., Johnson EJ, Russell RM, Krinsky NI, Yeum KJ, Edwards RB, Snodderly DM (1997) Dietary modification of human macular pigment. Invest Opthalmol Vis Sci 38, 1795–1801.
Hammond BR Jr., Wooten BR, Curran-Celentano J (2001) Carotenoids in the retina and lens: possible acute and chronic effects on human visual performance. Arch Biochem Biophys 385, 41–46.
Handleman GJ, Nightingale ZD, Lichenstein AH, Scaefer EJ, Blumberg JB (1999) Lutein and zeaxanthin in plasma after dietary supplementation with egg yolk. Am J Clin Nutr 70, 247–251.
Hartmann D, Thurmann PA, Spitzer V, Schalch W, Manner B, Cohn W (2004) Plasma kinetics of zeaxanthin and 3'-dehydro-lutein after multiple oral doses of synthetic zeaxanthin. Am J Clin Nutr 79, 410–417.
Hyman L, Neborsky R (2002) Risk factors for age-related macular degeneration: an update. Curr Opin Ophthalmol 13, 171–175.
Johnson EJ, Hammond BR, Yeum KJ, Qin J, Wang XD, Castaneda C, Snodderly DM, Russell RM (2000) Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr 71, 1555–1562.
Krinsky NI, Landrum JT, Bone RA (2003) Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr 23, 171–201.
Lam KW, But P (1999) The content of zeaxanthin in Gou Qi Zi, a potential health benefit to improve visual acuity. Food Chem 67, 173–176.
Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE (1997) A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res 65, 57–62.
Landrum JT, Bone RA, Moore LL, Gomez CM (1999) Analysis of zeaxanthin distribution within individual human retinas. Methods Enzymol 299, 457–467.
Landrum JT, Bone RA (2001) Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys 385, 28–40.
Leung IYF, Tso MOM, Li WWY, Lam TT (2001) Absorption and tissue distribution of zeaxanthin and lutein in rhesus monkeys after taking Fructus lycii (Gou Qi Zi) extract. Invest Ophthalmol Vis Sci 42, 466–471.
Mares-Perlman JA, Millen AE, Ficek TL, Hankinson SE (2002) The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease: an overview. J Nutr 132, 518S–524S.
Moeller SM, Jacques PF, Blumberg JB (2000) The potential role of dietary xanthophylls in cataract and age-related macular degeneration. J Am Coll Nutr 19 Suppl.522S–527S.
Mozaffarieh M, Sacu S, Wedrich A (2003) The role of the carotenoids, lutein and zeaxanthin, in protecting against age-related macular degeneration: a review based on controversial evidence. Nutr J 2, 20–31.
Olmedilla B, Granado F, Bianco I, Vaquere M, Cajigal C (2001) Lutein in patients with cataracts and age-related macular degeneration: a long-term supplementation study. J Sci Food Agric 81, 904–909.
Sommerburg O, Keunen JE, Bird AC, van Kuijk FJ (1998) Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol 82, 907–910.
Stokkermans TJW (2000) Treatment of age-related macular degeneration. Clin Eye Vis Care 12, 15–35.
Verschuren WM, Jacobs DR, Bloemberg BP, Kromhout D, Menotti A, Aravanis C, Blackburn H, Buzina R, Dontas AS, Fidanza F (1995) Serum total cholesterol and long term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the Seven Countries Study. JAMA 274, 131–136.
Weller P, Breithaupt DE (2003) Identification and quatification of zeaxanthin esters in plants using liquid chromatography-mass spectrometry. J Agric Food Chem 51, 7044–7049.
Zhou L, Leung I, Tso MOM, Lam KW (1999) The identification of dipalmityl zeaxanthin as the major carotenoid in Gou Qi Zi by high pressure liquid chromatography and mass spectrometry. J Ocul Pharmacol Ther 15, 557–565.